FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083424297> ?p ?o ?g. }

• W2083424297 endingPage "421" @default.
• W2083424297 startingPage "412" @default.
• W2083424297 abstract "The beneficial effects of therapeutic angiotensin-converting enzyme (ACE) inhibitor treatment against the worsening of glomerulosclerosis during the course of diabetic nephropathy have been widely documented. ACE inhibitors inhibit both angiotensin II formation and bradykinin (BK) degradation, thereby reducing angiotensin II type 1 (AT1) receptor activity and favoring B2-kinin receptor (B2 receptor) activation. Since the involvement of growth factors such as insulin-like growth factor (IGF-I) has been implicated in the early steps of diabetic nephropathy, we investigated the effect of BK on Erk 1 and 2 activation and cell proliferation by IGF-I.The activation of Erk 1 and 2 in mesangial cells (MCs) and isolated glomeruli (IG) was investigated by immunoprecipitation and Western blotting during activation of the IGF-I receptor in the presence or absence of BK and of protein kinase C (PKC), tyrosine-kinase and phosphatase selective inhibitors. Mesangial cell proliferation was assessed in vitro by cell counting.In untreated MCs and IG, when added separately, BK and IGF-I both activated Erk 1 and 2. In contrast, in MCs and IG pretreated with BK, the IGF-I-induced Erk 1 and 2 activation was dose-dependently reduced. The inhibitory effect of BK on IGF-I-induced activation of Erk 1 and 2 was completely abolished by addition of a B2 antagonist, by chelation of intracellular calcium and by tyrosine phosphatase inhibition. Additionally, BK reduced MC proliferation induced by IGF-I.A new inhibitory pathway of the early steps of IGF-I signaling by the B2 receptor is found both in cultured MCs and in IG, which involves a calcium-dependent tyrosine phosphatase activity. Recruitment of this mechanism may account for the beneficial effects of ACE inhibitor treatment on glomerulosclerosis associated with diabetic nephropathies." @default.
• W2083424297 created "2016-06-24" @default.
• W2083424297 creator A5009141968 @default.
• W2083424297 creator A5021776336 @default.
• W2083424297 creator A5038885109 @default.
• W2083424297 creator A5050703007 @default.
• W2083424297 creator A5052297527 @default.
• W2083424297 creator A5076078427 @default.
• W2083424297 creator A5088876597 @default.
• W2083424297 creator A5090325119 @default.
• W2083424297 date "2002-08-01" @default.
• W2083424297 modified "2023-10-16" @default.
• W2083424297 title "Inhibition of IGF-I–induced Erk 1 and 2 activation and mitogenesis in mesangial cells by bradykinin" @default.
• W2083424297 cites W1530748223 @default.
• W2083424297 cites W1792670415 @default.
• W2083424297 cites W1966120295 @default.
• W2083424297 cites W1969208588 @default.
• W2083424297 cites W1984901440 @default.
• W2083424297 cites W1993277902 @default.
• W2083424297 cites W2004450691 @default.
• W2083424297 cites W2008138729 @default.
• W2083424297 cites W2010240886 @default.
• W2083424297 cites W2016126193 @default.
• W2083424297 cites W2017740165 @default.
• W2083424297 cites W2034355953 @default.
• W2083424297 cites W2036258710 @default.
• W2083424297 cites W2037689163 @default.
• W2083424297 cites W2039998500 @default.
• W2083424297 cites W2075253318 @default.
• W2083424297 cites W2079051863 @default.
• W2083424297 cites W2082141855 @default.
• W2083424297 cites W2085347646 @default.
• W2083424297 cites W2086297580 @default.
• W2083424297 cites W2113362652 @default.
• W2083424297 cites W2120068491 @default.
• W2083424297 cites W2128129109 @default.
• W2083424297 cites W2134346602 @default.
• W2083424297 cites W2156041428 @default.
• W2083424297 cites W2159953124 @default.
• W2083424297 cites W2163570777 @default.
• W2083424297 cites W2231799708 @default.
• W2083424297 cites W2281391921 @default.
• W2083424297 cites W2341569738 @default.
• W2083424297 cites W2417164004 @default.
• W2083424297 cites W2615684303 @default.
• W2083424297 doi "https://doi.org/10.1046/j.1523-1755.2002.00475.x" @default.
• W2083424297 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12110002" @default.
• W2083424297 hasPublicationYear "2002" @default.
• W2083424297 type Work @default.
• W2083424297 sameAs 2083424297 @default.
• W2083424297 citedByCount "31" @default.
• W2083424297 countsByYear W20834242972012 @default.
• W2083424297 countsByYear W20834242972013 @default.
• W2083424297 countsByYear W20834242972016 @default.
• W2083424297 countsByYear W20834242972017 @default.
• W2083424297 countsByYear W20834242972020 @default.
• W2083424297 countsByYear W20834242972021 @default.
• W2083424297 crossrefType "journal-article" @default.
• W2083424297 hasAuthorship W2083424297A5009141968 @default.
• W2083424297 hasAuthorship W2083424297A5021776336 @default.
• W2083424297 hasAuthorship W2083424297A5038885109 @default.
• W2083424297 hasAuthorship W2083424297A5050703007 @default.
• W2083424297 hasAuthorship W2083424297A5052297527 @default.
• W2083424297 hasAuthorship W2083424297A5076078427 @default.
• W2083424297 hasAuthorship W2083424297A5088876597 @default.
• W2083424297 hasAuthorship W2083424297A5090325119 @default.
• W2083424297 hasBestOaLocation W20834242971 @default.
• W2083424297 hasConcept C126322002 @default.
• W2083424297 hasConcept C134018914 @default.
• W2083424297 hasConcept C170493617 @default.
• W2083424297 hasConcept C185592680 @default.
• W2083424297 hasConcept C2779131090 @default.
• W2083424297 hasConcept C2779591629 @default.
• W2083424297 hasConcept C2780091579 @default.
• W2083424297 hasConcept C2908929049 @default.
• W2083424297 hasConcept C42362537 @default.
• W2083424297 hasConcept C55493867 @default.
• W2083424297 hasConcept C57074206 @default.
• W2083424297 hasConcept C62478195 @default.
• W2083424297 hasConcept C71924100 @default.
• W2083424297 hasConcept C86803240 @default.
• W2083424297 hasConceptScore W2083424297C126322002 @default.
• W2083424297 hasConceptScore W2083424297C134018914 @default.
• W2083424297 hasConceptScore W2083424297C170493617 @default.
• W2083424297 hasConceptScore W2083424297C185592680 @default.
• W2083424297 hasConceptScore W2083424297C2779131090 @default.
• W2083424297 hasConceptScore W2083424297C2779591629 @default.
• W2083424297 hasConceptScore W2083424297C2780091579 @default.
• W2083424297 hasConceptScore W2083424297C2908929049 @default.
• W2083424297 hasConceptScore W2083424297C42362537 @default.
• W2083424297 hasConceptScore W2083424297C55493867 @default.
• W2083424297 hasConceptScore W2083424297C57074206 @default.
• W2083424297 hasConceptScore W2083424297C62478195 @default.
• W2083424297 hasConceptScore W2083424297C71924100 @default.
• W2083424297 hasConceptScore W2083424297C86803240 @default.
• W2083424297 hasIssue "2" @default.
• W2083424297 hasLocation W20834242971 @default.
• W2083424297 hasLocation W20834242972 @default.

• next